| abstract |
FIELD: medicine. n SUBSTANCE: invention refers to medicine, particularly to gastroenterology, and concerns clinical nutrition of the patients with chronic hepatitis C and being on integrated antiviral therapy. The therapy involves introduction of pegylated a-interferon with Ribavirin during 24-28 weeks. The clinical nutrition (CN) enables shift of pH tissues and biological fluids to alkaline and is implemented for one month prior to the beginning of medicinal therapy, therewith and six months thereafter. The CN implies consumption of great amount of potable water - up to 3-4 litres a day, deprivation of "oxidising" products, salt and pickled food. The CN implies consumption of diluted acetic acid and containing products. Herewith 0.25% aqueous solution of sodium citrate is introduced orally daily in a dose 100 ml per an hour. Introduction is repeated throughout 10 hours. Every two week of specified CN, a 7-day break is prescribed. n EFFECT: invention provides suppression replicative activity of hepatitis C virus and thereby improved clinical effectiveness. n 1 ex |